Are We Nearly There Yet? The Ongoing Journey of CAR-T Cell Therapies
CAR-T cells have a genetically engineered T-cell receptor (TCR) that directs their binding to cancer cells. In first-generation CARs, the TCR was engineered to expres...
Continue Reading →
